Search

everythinglearnresearchcommunity

for

Search:↓

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Ritlecitinib is a new treatment for severe hair loss in people 12 and older.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Roxithromycin, an antibiotic, can increase hair growth and might be used as a treatment for hair loss.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Cetirizine-loaded gel may effectively promote hair growth in alopecia.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

The compound 4c effectively inhibits the enzyme linked to hair loss.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Some cosmetics and dermatological drugs can cause allergic reactions and side effects, like skin irritation and systemic issues.

A reliable method was developed to measure Finasteride and Tadalafil in rat blood.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Topical clobetasol propionate 0.05% ointment is more effective in promoting hair regrowth in patients with alopecia areata than topical tacrolimus 0.1% ointment.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Clobetasol propionate, 0.05%, is more effective and safe for treating childhood alopecia areata than hydrocortisone, 1%.

Alpha-blockers are the most effective and widely used treatment for lower urinary tract symptoms, with minimal side effects.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Wedelolactone may help treat chronic diseases due to its strong antioxidant properties.

Tofacitinib may effectively treat folliculitis decalvans.

A woman was allergic to quinine in her anti-hair loss lotion.

Leflunomide with prednisone is effective and well-tolerated for lupus nephritis when cyclophosphamide can't be used.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.